Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens [9]

F. Van Leth, J.M. Prins, J.M.A. Lange, S.E. Geerlings

Research output: Contribution to JournalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)1722-1723
JournalAIDS
Volume19
Issue number15
DOIs
Publication statusPublished - 14 Oct 2005
Externally publishedYes

Cite this